We apologize for the inconvenience

The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

You will be automatically re-directed to People Search on yellowpages.com in .

CA Dermatology & Clinical Research Institute

Add to Favorites
Be the first to review!
Physicians & Surgeons, Dermatology, Clinics, Physicians & Surgeons

561 Saxony Pl, Encinitas, CA 92024

760-203-3839

OPEN NOW: 
Today: 8:00 am - 5:00 pm

REVIEWS write reviewWrite a Review

Be the first to review!
First-classBetter than mostAbout what I expectedNot the worst...Disappointing
DETAILS
General Info
California Dermatology & Clinical Research Institute (CDCRI) is a premier clinical research center in San Diego that is dedicated to the advancement of dermatologic therapy. CDCRI has access to the most cutting edge therapy in dermatology, using top of the line technology and innovative new techniques to treat various dermatological ailments, including but not limited to psoriasis, acne, eczema, warts, excessive sweating and many other conditions. We have decades of experience in executing clinical research in dermatology, so you can be sure you will be treated professionally and with respect. We offer this experience and professionalism in a friendly environment, so instead of feeling like you are in a stuffy research building, you feel like you are meeting your family doctor, giving you the time and attention you deserve. We offer our cutting-edge treatment at no cost to the patient and our research studies do not require health insurance. If you want access to amazing treatment and great therapy for dermatology-specific diseases and ailments, come to CDCRI.
Extra Phones

Fax: 760-203-3840

TollFree: 866-952-3795

Hours
Regular Hours
Mon - Fri:
Categories
Physicians & Surgeons, Dermatology, Clinics, Physicians & Surgeons, Skin Care
Payment Options
Suggest an Edit
Data provided by one or more of the following: Thryv, Data Axle, Yext.